| Primary information |
|---|
| OV_ID | OV_5019 |
| Virus Name | Vaccinia virus |
| Strain | VG9-EGFP |
| Virus type | DNA |
| Virus family | Poxviridae |
| Modification in virus genome | Addition of EGFP gene in tk locus |
| Virus alone | Yes |
| Virus in combination iwth drug/radiation | No |
| Immune gene induction in virus genome | No |
| Source of cell line | ATCC |
| Origin of cell line | Human lung cancer cell line |
| Cell line | A549 |
| Concentration of cell line | 1 |
| In-vitro toxicity | NA |
| Assay | MTT assay |
| In-vitro virus concentration | 0.1 MOI |
| In-vitro result | 58% cell viability after 3 days |
| Model organism | No |
| In-vivo virus concentration | No |
| In-vivo toxicity | NA |
| In-vivo result | No response |
| Mode of delivery | NA |
| Pathway induction | NA |
| Immunogenic effect | NA |
| Clinical trial | NA |
| PMID | 28465492 |